Effect of CA-SSR polymorphism and combined Fuzheng anti-cancer prescription on gefitinib in the treatment of advanced non-small cell lung cancer

HUANG Xi; XU Guo-feng; CHEN Wu-hua; ZHANG Xiao-xuan; PAN Zong-qi; ZHOU Da-lei

doi:10.13820/j.cnki.gdyx.20191306

Home>Articles>Effect of CA-SSR polymorphism and combined Fuzheng anti-cancer prescription on gefitinib in the treatment of advanced non-small cell lung cancer

DOI: 10.13820/j.cnki.gdyx.20191306

Effect of CA-SSR polymorphism and combined Fuzheng anti-cancer prescription on gefitinib in the treatment of advanced non-small cell lung cancer

HUANG Xi

XU Guo-feng

CHEN Wu-hua

ZHANG Xiao-xuan

PAN Zong-qi

ZHOU Da-lei

Machine-generated Keywords：

Publication Date：2019-08-25

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：7( 2293-2299 )

Guangdong Medical Journal

ISSN：1001-9448

Year, Vol.(Issue)：2019,40(16)